Anne de Ruijter

In March 2025, I joined the research groups of Koen van der Mijn and Lodewyk Wessels as a PhD student.

I studied Nanobiology at the Technical University of Delft and the Erasmus Medical Centre in Rotterdam, where I obtained my master’s degree in February 2025.

My project focusses on translational analysis of neoadjuvant therapy in patients with Renal Cell Carcinoma. Our goal is to identify and understand which patients are most likely to benefit from this therapy. This involves analysis of DNA-seq, RNA-seq and spatial transcriptomic data using pre- and post-treatment samples.